MARY BRANDT to Biomarkers
This is a "connection" page, showing publications MARY BRANDT has written about Biomarkers.
Connection Strength
0.125
-
A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut. 2014 Aug; 63(8):1284-92.
Score: 0.052
-
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials. Leukemia. 2017 02; 31(2):318-324.
Score: 0.016
-
Impaired Activity of Blood Coagulant Factor XIII in Patients with Necrotizing Enterocolitis. Sci Rep. 2015 Aug 17; 5:13119.
Score: 0.015
-
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology. 2015 Sep; 149(3):623-34.e8.
Score: 0.015
-
In situ hybridization utilizing a Y chromosome DNA probe. Use as a cell marker for hepatocellular transplantation. Transplantation. 1995 Jan 15; 59(1):109-11.
Score: 0.014
-
Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr. 2014 Mar; 164(3):607-12.e1-7.
Score: 0.013